TotalMarketCap

Greenland Mines

GRMLNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$49.269 M

$3.60 -7.93%

Close of 6 Nov 2026

As of 6 Nov 2026, Greenland Mines (GRML) has a market capitalization of $49.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$10.6M

Loss-making

Shares outstanding

158,850,637

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Greenland Mines lists more than one class of stock. Company figures above cover all classes combined.

GRMLW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #123Eloxx PharmaceuticalsELOX$52.1M
  2. #124MiNK TherapeuticsINKT$50.7M
  3. #125Greenland MinesGRML$49.3M
  4. #126Instil BioTIL$47.9M
  5. #127ImageneBioIMA$46.2M

What if Greenland Mines were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,063,203

Per share 573,112× higher

Bitcoin $1.53T

$111,636.32

Per share 31,010× higher

Apple $5.02T

$366,491.61

Per share 101,803× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Greenland Mines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.